Search
Showing results for "1"
News & Events
Clinic news December 2021Stay updated with the latest news and events from Clinikids in December 2021, focusing on child health innovations and community engagement. Explore more now!
Research
Epigenetics of the non-coding RNA nc886 across blood, adipose tissue and skeletal muscle in offspring exposed to diabetes in pregnancyDiabetes in pregnancy is associated with increased risk of long-term metabolic disease in the offspring, potentially mediated by in utero epigenetic variation. Previously, we identified multiple differentially methylated single CpG sites in offspring of women with gestational diabetes mellitus, but whether stretches of differentially methylated regions can also be identified in adolescent GDM offspring is unknown.
Research
S. aureus colonization in healthy Australian adults receiving an investigational S. aureus 3-antigen vaccineBased on descriptive analyses of this small study, S. aureus 3-antigen vaccine vaccination did not impact S. aureus acquisition or carriage
Research
Outcome measures for artificial pancreas clinical trials: A consensus reportResearch on and commercial development of the artificial pancreas (AP) continue to progress rapidly, and the AP promises to become a part of clinical care.
Scientific Launch Speakers Professor Liz Davis @ProfLizDavis @CDCTelethonKids Professor Davis is the Co-Director of the JDRF Global Centre of
Findings of a research study examining the characteristics of service use by a cohort of young people born between 1994-1997 who used four government services.
Contact us If you'd like to get in touch, please contact us by phone or email. Phone: 0400 450 240 Email: rhyme@telethonkids.org.au Background The
News & Events
Congratulations Dr Anna BoggissAnna has been awarded a three-year Fellowship to tackle the urgent gap in care in young Western Australians living with type 1 diabetes who are at heightened risk of developing eating disorders.
News & Events
Aussies publish first RCT of hybrid closed loop systemsA world-first clinical trial has shown young people with type 1 diabetes have better glycaemic control and quality of life while on hybrid closed loop (HCL) systems versus conventional treatments, Australian endocrinologists say.